Dignify Therapeutics Appoints Anthony Di Tonno As Chief Executive Officer

Mar 18, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Dignify Therapeutics

Anthony DiTonno

Research Triangle ParkBiotechnologyHealth Care

Description

Dignify Therapeutics announces the appointment of Anthony DiTonno as Chief Executive Officer. Mr. DiTonno will expand his duties while continuing in his role as Executive Chairman, leveraging his extensive experience in the pharmaceutical, biotechnology, and medical device industries.

Company Information

Company

Dignify Therapeutics

Location

Research Triangle Park, North Carolina, United States

About

Dignify Therapeutics is a clinical-stage biopharmaceutical company focused on developing practical and convenient treatments for bladder and bowel voiding dysfunctions. Founded by a team of serial entrepreneurs and internationally recognized scientists, the company leverages a proven drug repositioning strategy honed over two decades in urology and gastroenterology. Backed by funding from founders, top venture capital firms like RA Capital Management and Eshelman Ventures, as well as public and governmental programs including the NIH SBIR/STTR initiative, Dignify has secured approximately $18 million in support. Based at the First Flight Venture Center in Research Triangle Park, North Carolina, Dignify is committed to advancing therapies that significantly improve patients' quality of life.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months